Kaken Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	1,042	1,181	866	1,042	1,211	1,502
Market Cap Growth	0.52%	36.32%	-16.86%	-14.02%	-19.34%	-17.44%
Enterprise Value	768	674	454	544	697	916
Last Close Price	26.00	26.31	23.95	29.27	39.84	36.80
PE Ratio	-	12.68	16.32	25.45	15.41	12.39
PS Ratio	2.16	1.88	1.82	1.90	1.94	2.22
PB Ratio	1.12	1.16	0.91	1.01	1.06	1.22
P/TBV Ratio	1.29	1.33	0.96	1.07	1.14	1.23
P/FCF Ratio	-	6.90	182.95	19.06	14.21	13.39
P/OCF Ratio	-	5.94	50.83	14.96	11.03	11.55
EV/Sales Ratio	1.56	1.07	0.95	0.99	1.11	1.35
EV/EBITDA Ratio	-	4.28	5.60	6.85	4.33	5.04
EV/EBIT Ratio	-	4.80	7.22	9.04	4.96	5.69
EV/FCF Ratio	-	3.94	95.94	9.96	8.17	8.16
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.03	0.03
Debt / EBITDA Ratio	-	0.16	0.31	0.36	0.20	0.19
Debt / FCF Ratio	-	0.15	5.38	0.53	0.37	0.31
Net Debt / Equity Ratio	-0.29	-0.43	-0.43	-0.51	-0.51	-0.54
Net Debt / EBITDA Ratio	29.44	-2.81	-5.01	-6.66	-3.62	-3.65
Net Debt / FCF Ratio	-	-2.58	-85.86	-9.69	-6.84	-5.92
Asset Turnover	-	0.52	0.43	0.44	0.46	0.47
Inventory Turnover	-	1.96	2.05	2.19	2.28	2.48
Quick Ratio	3.11	3.01	4.68	4.49	4.98	4.60
Current Ratio	4.09	3.67	5.62	5.27	5.81	5.34
Return on Equity (ROE)	-	9.41%	5.72%	3.95%	6.96%	10.13%
Return on Assets (ROA)	-	7.26%	3.52%	3.02%	6.49%	6.92%
Return on Invested Capital (ROIC)	-3.86%	17.90%	10.48%	9.53%	18.01%	20.99%
Return on Capital Employed (ROCE)	-2.50%	13.10%	6.20%	5.50%	11.70%	12.50%
Earnings Yield	-2.34%	7.89%	6.13%	3.93%	6.49%	8.07%
FCF Yield	-	14.50%	0.55%	5.25%	7.03%	7.47%
Dividend Yield	4.70%	3.81%	4.14%	3.85%	3.10%	3.69%
Payout Ratio	-	51.62%	70.49%	103.84%	59.84%	43.35%
Buyback Yield / Dilution	0.01%	-1.13%	-0.44%	1.07%	1.59%	1.41%
Total Shareholder Return	4.79%	2.68%	3.70%	4.93%	4.69%	5.09%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.